|
DATE01/08/2026
|
SYMBOLALMS
|
NAMEForesite Labs, LLC
|
POSITION10 percent owner
|
ACTIONACQUIRED 117647 SHARES
|
|
DATE01/08/2026
|
SYMBOLALMS
|
NAMEForesite Labs, LLC
|
POSITION10 percent owner
|
ACTIONACQUIRED 294117 SHARES
|
|
DATE01/08/2026
|
SYMBOLALMS
|
NAMEForesite Capital Management VI LLC
|
POSITION10 percent owner
|
ACTIONACQUIRED 117647 SHARES
|
|
DATE01/08/2026
|
SYMBOLALMS
|
NAMEForesite Capital Management VI LLC
|
POSITION10 percent owner
|
ACTIONACQUIRED 294117 SHARES
|
|
DATE01/08/2026
|
SYMBOLALMS
|
NAMETananbaum James B.
|
POSITIONdirector, 10 percent owner:
|
ACTIONACQUIRED 117647 SHARES
|
|
DATE01/08/2026
|
SYMBOLALMS
|
NAMETananbaum James B.
|
POSITIONdirector, 10 percent owner:
|
ACTIONACQUIRED 294117 SHARES
|
|
DATE01/12/2026
|
SYMBOLACLX
|
NAMEHeery Christopher
|
POSITIONofficer: CHIEF MEDICAL OFFICER
|
ACTIONDISPOSED 6131 SHARES
|
|
DATE01/09/2026
|
SYMBOLLIND
|
NAMEBRESSLER BENJAMIN
|
POSITIONofficer: *Founder & CEO of NHA
|
ACTIONDISPOSED 69439 SHARES
|
|
DATE01/12/2026
|
SYMBOLLIND
|
NAMEBRESSLER BENJAMIN
|
POSITIONofficer: *Founder & CEO of NHA
|
ACTIONDISPOSED 222386 SHARES
|
|
DATE01/12/2026
|
SYMBOLLIND
|
NAMEBRESSLER BENJAMIN
|
POSITIONofficer: *Founder & CEO of NHA
|
ACTIONACQUIRED 222386 SHARES
|
|
DATE01/09/2026
|
SYMBOLLIND
|
NAMEBRESSLER BENJAMIN
|
POSITIONofficer: *Founder & CEO of NHA
|
ACTIONACQUIRED 69439 SHARES
|
|
DATE01/09/2026
|
SYMBOLLIND
|
NAMEBRESSLER BENJAMIN
|
POSITIONofficer: *Founder & CEO of NHA
|
ACTIONDISPOSED 69439 SHARES
|
|
DATE01/12/2026
|
SYMBOLLIND
|
NAMEBRESSLER BENJAMIN
|
POSITIONofficer: *Founder & CEO of NHA
|
ACTIONDISPOSED 222386 SHARES
|
|
DATE01/12/2026
|
SYMBOLWRAP
|
NAMESavas Marc
|
POSITIONdirector
|
ACTIONACQUIRED 7063 SHARES
|
|
DATE01/12/2026
|
SYMBOLWRAP
|
NAMESrinivasan Rajiv
|
POSITIONdirector
|
ACTIONACQUIRED 3346 SHARES
|
|
DATE01/12/2026
|
SYMBOLWRAP
|
NAMEBernstein Bruce
|
POSITIONdirector
|
ACTIONACQUIRED 10409 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMENathan Lloyd
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEMatter David
|
POSITIONdirector
|
ACTIONACQUIRED 30612 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEMatter David
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEDrapkin Matthew A
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEDrapkin Matthew A
|
POSITIONdirector
|
ACTIONACQUIRED 61224 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEDrapkin Matthew A
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMESchwartz David W.
|
POSITIONdirector
|
ACTIONACQUIRED 32877 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMESchwartz David W.
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/11/2026
|
SYMBOLAEHR
|
NAMERICHMOND DONALD P. II
|
POSITIONofficer: VP of Engineering
|
ACTIONDISPOSED 486 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMESmith Booker
|
POSITIONdirector
|
ACTIONACQUIRED 30612 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMESmith Booker
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEParmelee James P
|
POSITIONdirector
|
ACTIONACQUIRED 48980 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEParmelee James P
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/12/2026
|
SYMBOLNYC
|
NAMESCHORSCH NICHOLAS S
|
POSITION10 percent owner
|
ACTIONACQUIRED 1224 SHARES
|
|
DATE01/09/2026
|
SYMBOLNYC
|
NAMESCHORSCH NICHOLAS S
|
POSITION10 percent owner
|
ACTIONACQUIRED 968 SHARES
|
|
DATE01/08/2026
|
SYMBOLNYC
|
NAMESCHORSCH NICHOLAS S
|
POSITION10 percent owner
|
ACTIONACQUIRED 968 SHARES
|
|
DATE01/07/2026
|
SYMBOLNYC
|
NAMESCHORSCH NICHOLAS S
|
POSITION10 percent owner
|
ACTIONACQUIRED 968 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEScheyer Eric J
|
POSITIONdirector
|
ACTIONACQUIRED 30612 SHARES
|
|
DATE01/08/2026
|
SYMBOLGEG
|
NAMEScheyer Eric J
|
POSITIONdirector
|
ACTIONACQUIRED 26531 SHARES
|
|
DATE01/08/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 11565 SHARES
|
|
DATE01/08/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 8135 SHARES
|
|
DATE01/08/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 300 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 1401 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 6067 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 10677 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 1855 SHARES
|
|
DATE01/08/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 11515 SHARES
|
|
DATE01/08/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 8085 SHARES
|
|
DATE01/08/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 400 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 2151 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 6955 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 10519 SHARES
|
|
DATE01/09/2026
|
SYMBOLBBIO
|
NAMEKumar Neil
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 375 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMESmith Jeffrey T L
|
POSITIONofficer: EVP & Chief Medical Officer
|
ACTIONACQUIRED 17666 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMESmith Jeffrey T L
|
POSITIONofficer: EVP & Chief Medical Officer
|
ACTIONDISPOSED 17666 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMESmith Jeffrey T L
|
POSITIONofficer: EVP & Chief Medical Officer
|
ACTIONDISPOSED 9310 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMECiongoli Gregory Austin
|
POSITIONdirector
|
ACTIONACQUIRED 11500 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMECiongoli Gregory Austin
|
POSITIONdirector
|
ACTIONACQUIRED 7700 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMENeu Kelvin
|
POSITIONdirector
|
ACTIONACQUIRED 11500 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMENeu Kelvin
|
POSITIONdirector
|
ACTIONACQUIRED 7700 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMELandry Robert E
|
POSITIONdirector
|
ACTIONACQUIRED 11500 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMELandry Robert E
|
POSITIONdirector
|
ACTIONACQUIRED 7700 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMECesano Alessandra
|
POSITIONdirector
|
ACTIONACQUIRED 11500 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMECesano Alessandra
|
POSITIONdirector
|
ACTIONACQUIRED 7700 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMESchochet Barry P.
|
POSITIONdirector
|
ACTIONACQUIRED 2382 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMECampoy Carlos
|
POSITIONdirector
|
ACTIONACQUIRED 11500 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMECampoy Carlos
|
POSITIONdirector
|
ACTIONACQUIRED 7700 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMERodgers Stephan
|
POSITIONdirector
|
ACTIONACQUIRED 1881 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMEOhlendorf Mark W
|
POSITIONdirector
|
ACTIONACQUIRED 1881 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMEMCGUIGAN STUART M
|
POSITIONdirector
|
ACTIONACQUIRED 1881 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMEELSON CHARLES M
|
POSITIONdirector
|
ACTIONACQUIRED 1881 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMERush Gregory S
|
POSITIONdirector
|
ACTIONACQUIRED 2508 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMEHoeflinger Erin
|
POSITIONdirector
|
ACTIONACQUIRED 2382 SHARES
|
|
DATE01/10/2026
|
SYMBOLEHAB
|
NAMEBolton Jeffrey
|
POSITIONdirector
|
ACTIONACQUIRED 3761 SHARES
|
|
DATE01/09/2026
|
SYMBOLTRUP
|
NAMELOW MURRAY B
|
POSITIONdirector
|
ACTIONACQUIRED 23213 SHARES
|
|
DATE01/09/2026
|
SYMBOLTRUP
|
NAMELOW MURRAY B
|
POSITIONdirector
|
ACTIONDISPOSED 23213 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMahony Susan
|
POSITIONdirector
|
ACTIONACQUIRED 11500 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMahony Susan
|
POSITIONdirector
|
ACTIONACQUIRED 7700 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMoore Paul Andrew
|
POSITIONofficer: Chief Scientific Officer
|
ACTIONACQUIRED 70000 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMoore Paul Andrew
|
POSITIONofficer: Chief Scientific Officer
|
ACTIONACQUIRED 66000 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMoore Paul Andrew
|
POSITIONofficer: Chief Scientific Officer
|
ACTIONACQUIRED 17666 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMoore Paul Andrew
|
POSITIONofficer: Chief Scientific Officer
|
ACTIONDISPOSED 9560 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMoore Paul Andrew
|
POSITIONofficer: Chief Scientific Officer
|
ACTIONACQUIRED 47000 SHARES
|
|
DATE01/12/2026
|
SYMBOLZYME
|
NAMEMoore Paul Andrew
|
POSITIONofficer: Chief Scientific Officer
|
ACTIONDISPOSED 17666 SHARES
|
|
DATE01/11/2026
|
SYMBOLAEHR
|
NAMEErickson Gayn
|
POSITIONdirector, officer: President and CEO
|
ACTIONDISPOSED 3531 SHARES
|
|
DATE01/11/2026
|
SYMBOLAEHR
|
NAMEROGERS VERNON
|
POSITIONofficer: Exec VP of Sales & Mktg.
|
ACTIONDISPOSED 576 SHARES
|
|
DATE01/12/2026
|
SYMBOLHSCS
|
NAMEWells David R.
|
POSITIONdirector
|
ACTIONACQUIRED 15000 SHARES
|
|
DATE01/12/2026
|
SYMBOLHSCS
|
NAMEBent Bruce
|
POSITIONdirector
|
ACTIONACQUIRED 15000 SHARES
|
|
DATE01/12/2026
|
SYMBOLWYNN
|
NAMEKRUM JACQUI
|
POSITIONofficer: EVP and General Counsel
|
ACTIONDISPOSED 383 SHARES
|
|
DATE01/12/2026
|
SYMBOLWYNN
|
NAMECAMERON-DOE JULIE
|
POSITIONofficer: CFO
|
ACTIONDISPOSED 943 SHARES
|
|
DATE01/12/2026
|
SYMBOLWYNN
|
NAMEBillings Craig Scott
|
POSITIONdirector, officer: CEO
|
ACTIONDISPOSED 4939 SHARES
|
|
DATE01/08/2026
|
SYMBOLLXU
|
NAMEGOLSEN BARRY H
|
POSITIONdirector
|
ACTIONDISPOSED 87772 SHARES
|
|
DATE01/09/2026
|
SYMBOLLXU
|
NAMEGOLSEN BARRY H
|
POSITIONdirector
|
ACTIONDISPOSED 56744 SHARES
|
|
DATE01/08/2026
|
SYMBOLLXU
|
NAMEGOLSEN BARRY H
|
POSITIONdirector
|
ACTIONDISPOSED 12486 SHARES
|
|
DATE01/08/2026
|
SYMBOLLXU
|
NAMEGOLSEN BARRY H
|
POSITIONdirector
|
ACTIONDISPOSED 18695 SHARES
|
|
DATE11/06/2025
|
SYMBOLLRHC
|
NAMELA ROSA JOSEPH
|
POSITIONdirector, 10 percent owner, officer: CEO, interim CFO
|
ACTIONACQUIRED 255272 SHARES
|
|
DATE01/08/2026
|
SYMBOLLRHC
|
NAMELA ROSA JOSEPH
|
POSITIONdirector, 10 percent owner, officer: CEO, interim CFO
|
ACTIONDISPOSED 200 SHARES
|
|
DATE11/06/2025
|
SYMBOLLRHC
|
NAMELA ROSA JOSEPH
|
POSITIONdirector, 10 percent owner, officer: CEO, interim CFO
|
ACTIONDISPOSED 255272 SHARES
|
|
DATE01/08/2026
|
SYMBOLZM
|
NAMEBawa Aparna
|
POSITIONofficer: Chief Operating Officer
|
ACTIONDISPOSED 11963 SHARES
|
|
DATE01/08/2026
|
SYMBOLZM
|
NAMEBawa Aparna
|
POSITIONofficer: Chief Operating Officer
|
ACTIONACQUIRED 21392 SHARES
|
|
DATE01/08/2026
|
SYMBOLZM
|
NAMEBawa Aparna
|
POSITIONofficer: Chief Operating Officer
|
ACTIONDISPOSED 9429 SHARES
|
|
DATE01/08/2026
|
SYMBOLZM
|
NAMEBawa Aparna
|
POSITIONofficer: Chief Operating Officer
|
ACTIONDISPOSED 9255 SHARES
|
|
DATE01/08/2026
|
SYMBOLZM
|
NAMEYuan Eric S.
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONDISPOSED 38281 SHARES
|
|
DATE01/08/2026
|
SYMBOLZM
|
NAMEYuan Eric S.
|
POSITIONdirector, officer: Chief Executive Officer
|
ACTIONACQUIRED 68453 SHARES
|
